Text Version
Entrez PubMed Overview Help | FAQ Tutorial New/Noteworthy E-Utilities
PubMed Services Journals Database MeSH Database Single Citation Matcher Batch Citation Matcher Clinical Queries LinkOut Cubby
Related Resources Order Documents NLM
Gateway TOXNET Consumer
Health Clinical Alerts ClinicalTrials.gov PubMed
Central
Privacy Policy
|
|
-
Citalopram-induced
photopigmentation.
Inaloz HS, Kirtak N, Herken H,
Ozgoztasi O, Aynacioglu AS.
Department of Dermatology,
University of Gaziantep Faculty of Medicine, Turkey.
Citalopram
is one of the newer and most potent selective serotonin re-uptake
inhibitor (SSRI) drugs. It has a well-established antidepressive action
with a favorable adverse event profile. We present a fifty-year-old
woman with diffuse photopigmentation who had been diagnosed as suffering
from depression. The patient was given citalopram (40 mg/day) for her
psychiatric condition and diffuse photopigmentation was noted
thereafter. To our knowledge, such an adverse event has not been
reported previously.
Publication Types:
PMID: 11804072 [PubMed - indexed for
MEDLINE]
|